Recurrent myocardial infarction in a young patient with PAI-1 4G/4G mutation

References (1)

1. Isordia-Salas I, Leanos-Miranda A, Sainz IM, Reyes-Maldonado E, Borrayo-Sanchez G. Association of the plasminogen activator inhibitor-1 Gene 4G/5G polymorphism with ST elevation acute myocardial infarction in young patients. Rev Esp Cardiol 2009; 62: 365-72. [CrossRef] 2. Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review. Atherosclerosis 1992; 95: 105-17. [CrossRef] 3. Huber K. Plasminogen activator inhibitor type-1 (part two): role for failure of thrombolytic therapy. PAI-1 resistance as a potential benefit for new fibrinolytic agents. J Thromb Thrombolysis 2001; 11: 195-202. [CrossRef] 4. Sayer JW, Gutteridge C, Syndercombe-Court D, Wilkinson P Timmis AD. Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease: effects of beta-adrenoreceptor blockers and angiotensin- converting enzyme inhibitors. J Am Coll Cardiol 1998;32: 1962-8. [CrossRef] 5. Dawson SJ, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhbitor-1 (PAI-1) gene respond differently to interleukin-I HepG2 cells. J Biol Chem 1993; 268: 10739-45. 6. Lima LM, Carvalho MD, Fonseca Neto CP Garcia JC, Sousa MO. PAI-1 4G/5G polymorphism and plasma levels association in patients with coro- nary artery disease. Arq Bras Cardiol 2011; 97: 389-462. 7. Özkan B, Çağlıyan CE, Elbasan Z, Uysal OK, Kalkan GY, Bozkurt M, et al. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy. Coron Artery Dis 2012; 23: 400-3. [CrossRef] 8. Gong LL, Peng JH, Han FF, Zhu J, Fan LH, Wang YH, et al. Association of tissue plasminogen activator and plasminogen activator inhibitor polymor- phism with myocardial infarction: a meta-analysis. Thromb Res 2012; 130: e43-51. [CrossRef] 9. Rallidis LS, Megalou AA, Papageorgakis NH, Trikas AG, Chatzidimitriou GI, Tsitouris GK. Plasminogen activator inhibitor-1 is elevated in the children of men with premature myocardial infarction. Thromb Haemost 1996; 76: 417-21. 10. Önalan O, Balta G, Oto A, Kabakçı G, Tokgözoğlu L, Aytemir K, et al. Plasminogen activator inhibitor-1 4G4G genotype is associated with myo- cardial infarction but not with stable coronary artery disease. J Thromb Thrombolysis 2008; 26: 211-7. [CrossRef]